News

15/03/2022

A new tool improves adaptation of healthcare guidelines by different countries and organisations

IIB Sant Pau researchers lead the development of a new reporting tool to improve healthcare guidelines. RIGHT-Ad@pt Checklist is the new reporting tool, which ensures transparency and standardization...

10/03/2022

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Researchers from the Research Institute of the Hospital de Sant Pau – IIB Sant Pan, the Hospital Clínic-IDIBAPS and the CIBERER, propose a biomarker that could accurately and non-invasively identif...

09/02/2022

Scientists discover a micro-RNA that can promote the development of atherosclerosis in patients with coronary disease

A study by IIB Sant Pau, CIBERDEM and IDIBELL shows that miR-125b affects the ability of HDL lipoproteins to extract colesterol from macrophages and smooth muscle cells of the arterial wall, accelerat...

04/02/2022

Nanoligent, Sant Pau’s spin-off, raises €1M in series seed financing

Nanoligent SL, a biotech company spin-off of the Sant Pau Research Institute and Universitat Autònoma de Barcelona specialized in the development of nanotechnology-based cancer treatments, today anno...

20/12/2021

Patients with stroke and COVID-19 have more severe strokes and higher mortality

A multicenter study, led by neurologists at the Research Instituto of the Sant Pau Hospital and with the participation of the main Catalan hospitals, analyses the relationship between stroke and COVID...